Clinical trial NCT01139281 - References

Hearing Loss — The Protective Effect of Ginkgo Biloba Extract on Cisplatin-induced Ototoxicity in Humans

Citation(s)

•   Biro K, Noszek L, Prekopp P, Nagyiványi K, Géczi L, Gaudi I, Bodrogi I
  Characteristics and risk factors of cisplatin-induced ototoxicity in testicular cancer patients detected by distortion product otoacoustic emission. Oncology. 2006;70(3):177-84. Epub 2006 Jun 2.
•   Blakley BW, Myers SF
  Patterns of hearing loss resulting from cis-platinum therapy. Otolaryngol Head Neck Surg. 1993 Sep;109(3 Pt 1):385-91.
•   Bonfils P, Avan P
  Distortion-product otoacoustic emissions. Values for clinical use. Arch Otolaryngol Head Neck Surg. 1992 Oct;118(10):1069-76.
•   Bridi R, Crossetti FP, Steffen VM, Henriques AT
  The antioxidant activity of standardized extract of Ginkgo biloba (EGb 761) in rats. Phytother Res. 2001 Aug;15(5):449-51.
•   Campbell K
  Ototoxicity: understanding oxidative mechanisms. J Am Acad Audiol. 2003 Apr;14(3):121-3. Review.
•   Campbell KC, Durrant J
  Audiologic monitoring for ototoxicity. Otolaryngol Clin North Am. 1993 Oct;26(5):903-14. Review.
•   Christen Y, Maixent JM
  What is Ginkgo biloba extract EGb 761? An overview--from molecular biology to clinical medicine. Cell Mol Biol (Noisy-le-grand). 2002 Sep;48(6):601-11. Review.
•   Dhooge I, Dhooge C, Geukens S, De Clerck B, De Vel E, Vinck BM
  Distortion product otoacoustic emissions: an objective technique for the screening of hearing loss in children treated with platin derivatives. Int J Audiol. 2006 Jun;45(6):337-43.
•   Diamond BJ, Shiflett SC, Feiwel N, Matheis RJ, Noskin O, Richards JA, Schoenberger NE
  Ginkgo biloba extract: mechanisms and clinical indications. Arch Phys Med Rehabil. 2000 May;81(5):668-78. Review.
•   Franklin DJ, McCoy MJ, Martin GK, Lonsbury-Martin BL
  Test/retest reliability of distortion-product and transiently evoked otoacoustic emissions. Ear Hear. 1992 Dec;13(6):417-29.
•   Fukaya H, Kanno H
  [Experimental studies of the protective effect of ginkgo biloba extract (GBE) on cisplatin-induced toxicity in rats]. Nihon Jibiinkoka Gakkai Kaiho. 1999 Jul;102(7):907-17. Japanese.
•   Gardner CD, Zehnder JL, Rigby AJ, Nicholus JR, Farquhar JW
  Effect of Ginkgo biloba (EGb 761) and aspirin on platelet aggregation and platelet function analysis among older adults at risk of cardiovascular disease: a randomized clinical trial. Blood Coagul Fibrinolysis. 2007 Dec;18(8):787-93.
•   Gorga MP, Neely ST, Ohlrich B, Hoover B, Redner J, Peters J
  From laboratory to clinic: a large scale study of distortion product otoacoustic emissions in ears with normal hearing and ears with hearing loss. Ear Hear. 1997 Dec;18(6):440-55.
•   Gorga MP, Stover L, Neely ST, Montoya D
  The use of cumulative distributions to determine critical values and levels of confidence for clinical distortion product otoacoustic emission measurements. J Acoust Soc Am. 1996 Aug;100(2 Pt 1):968-77.
•   Hatzopoulos S, Di Stefano M, Campbell KC, Falgione D, Ricci D, Rosignoli M, Finesso M, Albertin A, Previati M, Capitani S, Martini A
  Cisplatin ototoxicity in the Sprague Dawley rat evaluated by distortion product otoacoustic emissions. Audiology. 2001 Sep-Oct;40(5):253-64.
•   Hibatallah J, Carduner C, Poelman MC
  In-vivo and in-vitro assessment of the free-radical-scavenger activity of Ginkgo flavone glycosides at high concentration. J Pharm Pharmacol. 1999 Dec;51(12):1435-40.
•   Huang T, Cheng AG, Stupak H, Liu W, Kim A, Staecker H, Lefebvre PP, Malgrange B, Kopke R, Moonen G, Van De Water TR
  Oxidative stress-induced apoptosis of cochlear sensory cells: otoprotective strategies. Int J Dev Neurosci. 2000 Apr-Jun;18(2-3):259-70. Review.
•   Huang X, Whitworth CA, Rybak LP
  Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats. Otol Neurotol. 2007 Sep;28(6):828-33.
•   Kaltenbach JA, Church MW, Blakley BW, McCaslin DL, Burgio DL
  Comparison of five agents in protecting the cochlea against the ototoxic effects of cisplatin in the hamster. Otolaryngol Head Neck Surg. 1997 Nov;117(5):493-500.
•   Kemp DT, Ryan S, Bray P
  A guide to the effective use of otoacoustic emissions. Ear Hear. 1990 Apr;11(2):93-105.
•   Kimberley BP
  Applications of distortion-product emissions to an otological practice. Laryngoscope. 1999 Dec;109(12):1908-18. Review.
•   Knight KR, Kraemer DF, Winter C, Neuwelt EA
  Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions. J Clin Oncol. 2007 Apr 1;25(10):1190-5.
•   Kobuchi H, Droy-Lefaix MT, Christen Y, Packer L
  Ginkgo biloba extract (EGb 761): inhibitory effect on nitric oxide production in the macrophage cell line RAW 264.7. Biochem Pharmacol. 1997 Mar 21;53(6):897-903.
•   Komune S, Asakuma S, Snow JB Jr
  Pathophysiology of the ototoxicity of cis-diamminedichloroplatinum. Otolaryngol Head Neck Surg. 1981 Mar-Apr;89(2):275-82.
•   Kushner BH, Budnick A, Kramer K, Modak S, Cheung NK
  Ototoxicity from high-dose use of platinum compounds in patients with neuroblastoma. Cancer. 2006 Jul 15;107(2):417-22.
•   Laurell G, Bagger-Sjöbäck D
  Dose-dependent inner ear changes after i.v. administration of cisplatin. J Otolaryngol. 1991 Jun;20(3):158-67.
•   Le Bars PL, Kastelan J
  Efficacy and safety of a Ginkgo biloba extract. Public Health Nutr. 2000 Dec;3(4A):495-9. Review.
•   Lonsbury-Martin BL, Whitehead ML, Martin GK
  Clinical applications of otoacoustic emissions. J Speech Hear Res. 1991 Oct;34(5):964-81. Review.
•   Mahadevan S, Park Y
  Multifaceted therapeutic benefits of Ginkgo biloba L.: chemistry, efficacy, safety, and uses. J Food Sci. 2008 Jan;73(1):R14-9. doi: 10.1111/j.1750-3841.2007.00597.x. Review.
•   Maitra I, Marcocci L, Droy-Lefaix MT, Packer L
  Peroxyl radical scavenging activity of Ginkgo biloba extract EGb 761. Biochem Pharmacol. 1995 May 26;49(11):1649-55.
•   Marcocci L, Packer L, Droy-Lefaix MT, Sekaki A, Gardès-Albert M
  Antioxidant action of Ginkgo biloba extract EGb 761. Methods Enzymol. 1994;234:462-75.
•   McKenna DJ, Jones K, Hughes K
  Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications. Altern Ther Health Med. 2001 Sep-Oct;7(5):70-86, 88-90. Review.
•   Meyerhoff WL, Maale GE, Yellin W, Roland PS
  Audiologic threshold monitoring of patients receiving ototoxic drugs. Preliminary report. Ann Otol Rhinol Laryngol. 1989 Dec;98(12 Pt 1):950-4.
•   Ohlms LA, Lonsbury-Martin BL, Martin GK
  The clinical application of acoustic distortion products. Otolaryngol Head Neck Surg. 1990 Jul;103(1):52-9.
•   Ozturan O, Jerger J, Lew H, Lynch GR
  Monitoring of cisplatin ototoxicity by distortion-product otoacoustic emissions. Auris Nasus Larynx. 1996;23:147-51.
•   Palomar García V, Abdulghani Martínez F, Bodet Agustí E, Andreu Mencía L, Palomar Asenjo V
  Drug-induced otoxicity: current status. Acta Otolaryngol. 2001 Jul;121(5):569-72. Review.
•   Pincemail J, Dupuis M, Nasr C, Hans P, Haag-Berrurier M, Anton R, Deby C
  Superoxide anion scavenging effect and superoxide dismutase activity of Ginkgo biloba extract. Experientia. 1989 Aug 15;45(8):708-12.
•   Probst R, Hauser R
  Distortion product otoacoustic emissions in normal and hearing-impaired ears. Am J Otolaryngol. 1990 Jul-Aug;11(4):236-43.
•   Rademaker-Lakhai JM, Crul M, Zuur L, Baas P, Beijnen JH, Simis YJ, van Zandwijk N, Schellens JH
  Relationship between cisplatin administration and the development of ototoxicity. J Clin Oncol. 2006 Feb 20;24(6):918-24.
•   Ravi R, Somani SM, Rybak LP
  Mechanism of cisplatin ototoxicity: antioxidant system. Pharmacol Toxicol. 1995 Jun;76(6):386-94.
•   Ress BD, Sridhar KS, Balkany TJ, Waxman GM, Stagner BB, Lonsbury-Martin BL
  Effects of cis-platinum chemotherapy on otoacoustic emissions: the development of an objective screening protocol. Third place--Resident Clinical Science Award 1998. Otolaryngol Head Neck Surg. 1999 Dec;121(6):693-701.
•   Rybak LP, Husain K, Morris C, Whitworth C, Somani S
  Effect of protective agents against cisplatin ototoxicity. Am J Otol. 2000 Jul;21(4):513-20.
•   Rybak LP, Kelly T
  Ototoxicity: bioprotective mechanisms. Curr Opin Otolaryngol Head Neck Surg. 2003 Oct;11(5):328-33. Review.
•   Rybak LP, Ramkumar V
  Ototoxicity. Kidney Int. 2007 Oct;72(8):931-5. Epub 2007 Jul 25. Review.
•   Rybak LP, Whitworth C, Somani S
  Application of antioxidants and other agents to prevent cisplatin ototoxicity. Laryngoscope. 1999 Nov;109(11):1740-4.
•   Rybak LP, Whitworth CA, Mukherjea D, Ramkumar V
  Mechanisms of cisplatin-induced ototoxicity and prevention. Hear Res. 2007 Apr;226(1-2):157-67. Epub 2006 Nov 17. Review.
•   Rybak LP, Whitworth CA
  Ototoxicity: therapeutic opportunities. Drug Discov Today. 2005 Oct 1;10(19):1313-21. Review.
•   Rybak LP
  Mechanisms of cisplatin ototoxicity and progress in otoprotection. Curr Opin Otolaryngol Head Neck Surg. 2007 Oct;15(5):364-9. Review.
•   Sie KC, Norton SJ
  Changes in otoacoustic emissions and auditory brain stem response after cis-platinum exposure in gerbils. Otolaryngol Head Neck Surg. 1997 Jun;116(6 Pt 1):585-92.
•   Singh B, Kaur P, Gopichand, Singh RD, Ahuja PS
  Biology and chemistry of Ginkgo biloba. Fitoterapia. 2008 Sep;79(6):401-18. doi: 10.1016/j.fitote.2008.05.007. Epub 2008 Jun 27. Review.
•   Sockalingam R, Freeman S, Cherny TL, Sohmer H
  Effect of high-dose cisplatin on auditory brainstem responses and otoacoustic emissions in laboratory animals. Am J Otol. 2000 Jul;21(4):521-7.
•   Stavroulaki P, Apostolopoulos N, Segas J, Tsakanikos M, Adamopoulos G
  Evoked otoacoustic emissions--an approach for monitoring cisplatin induced ototoxicity in children. Int J Pediatr Otorhinolaryngol. 2001 May 31;59(1):47-57.
•   Stover L, Gorga MP, Neely ST, Montoya D
  Toward optimizing the clinical utility of distortion product otoacoustic emission measurements. J Acoust Soc Am. 1996 Aug;100(2 Pt 1):956-67.
•   Toral-Martiñón R, Shkurovich-Bialik P, Collado-Corona MA, Mora-Magaña I, Goldgrub-Listopad S, Shkurovich-Zaslavsky M
  Distortion product otoacoustic emissions test is useful in children undergoing cisplatin treatment. Arch Med Res. 2003 May-Jun;34(3):205-8.
•   Vermorken JB, Kapteijn TS, Hart AA, Pinedo HM
  Ototoxicity of cis-diamminedichloroplatinum (II): influence of dose, schedule and mode of administration. Eur J Cancer Clin Oncol. 1983 Jan;19(1):53-8.
•   Zorowka PG, Schmitt HJ, Gutjahr P
  Evoked otoacoustic emissions and pure tone threshold audiometry in patients receiving cisplatinum therapy. Int J Pediatr Otorhinolaryngol. 1993 Jan;25(1-3):73-80.

The Protective Effect of Ginkgo Biloba Extract on Cisplatin-Induced Ototoxicity in Humans Beings Evaluated by Distortion Product Otoacoustic Emissions

Details for clinical trial NCT01139281